Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia
Open Access
- 1 October 2015
- journal article
- case report
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (10), 5903-5908
- https://doi.org/10.1128/aac.00655-15
Abstract
New antibiotic options are urgently needed for the treatment of carbapenem-resistant Enterobacteriaceae infections. We report a 64-year-old female with prolonged hospitalization following an intestinal transplant who developed refractory bacteremia due to a serine carbapenemase-producing pandrug-resistant isolate of Klebsiella pneumoniae. After failing multiple antimicrobial regimens, the patient was successfully treated.Keywords
This publication has 29 references indexed in Scilit:
- Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimenInternational Journal of Infectious Diseases, 2015
- Breakpoints for carbapenemase-producing Enterobacteriaceae: Is the problem solved?Enfermedades Infecciosas y Microbiología Clínica, 2014
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infectionsDiagnostic Microbiology and Infectious Disease, 2011
- Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patientsJournal of Antimicrobial Chemotherapy, 2010
- Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection modelClinical Microbiology & Infection, 2007
- The Pharmacokinetic and Pharmacodynamic Profile of TigecyclineClinical Infectious Diseases, 2005
- In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli Clinical IsolatesAntimicrobial Agents and Chemotherapy, 1999
- Beta-lactamase inhibitors from laboratory to clinicClinical Microbiology Reviews, 1988
- Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976